Small Efficient Cell-penetrating Peptides Derived from Scorpion Toxin Maurocalcine*

Background: This study aimed at developing a new set of maurocalcine-derived cell-penetrating peptides from truncation. Results: Several truncated peptides were designed and evaluated for Cy5 dye cell penetration. Conclusion: All truncated peptides are competitive cell-penetrating peptides, many of them comparing favorably well with TAT. Significance: Maurocalcine-derived truncated cell-penetrating peptides differ in their properties, enlarging the potential fields of applications. Maurocalcine is the first demonstrated example of an animal toxin peptide with efficient cell penetration properties. Although it is a highly competitive cell-penetrating peptide (CPP), its relatively large size of 33 amino acids and the presence of three internal disulfide bridges may hamper its development for in vitro and in vivo applications. Here, we demonstrate that several efficient CPPs can be derived from maurocalcine by replacing Cys residues by isosteric 2-aminobutyric acid residues and sequence truncation down to peptides of up to 9 residues in length. A surprising finding is that all of the truncated maurocalcine analogues possessed cell penetration properties, indicating that the maurocalcine is a highly specialized CPP. Careful examination of the cell penetration properties of the truncated analogues indicates that several maurocalcine-derived peptides should be of great interest for cell delivery applications where peptide size matters.

[1]  M. Ronjat,et al.  d-Maurocalcine, a Pharmacologically Inert Efficient Cell-penetrating Peptide Analogue* , 2010, The Journal of Biological Chemistry.

[2]  M. De Waard,et al.  Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231. , 2009, Cancer letters.

[3]  J. Bréard,et al.  Conjugation of doxorubicin to cell penetrating peptides sensitizes human breast MDA-MB 231 cancer cells to endogenous TRAIL-induced apoptosis , 2009, Apoptosis.

[4]  M. Ronjat,et al.  Maurocalcine as a Non Toxic Drug Carrier Overcomes Doxorubicin Resistance in the Cancer Cell Line MDA-MB 231 , 2009, Pharmaceutical Research.

[5]  M. Ronjat,et al.  Design of a Disulfide-less, Pharmacologically Inert, and Chemically Competent Analog of Maurocalcine for the Efficient Transport of Impermeant Compounds into Cells* , 2008, Journal of Biological Chemistry.

[6]  M. Ronjat,et al.  Charged surface area of maurocalcine determines its interaction with the skeletal ryanodine receptor. , 2008, Biophysical journal.

[7]  M. Ronjat,et al.  Direct Peptide Interaction with Surface Glycosaminoglycans Contributes to the Cell Penetration of Maurocalcine* , 2008, Journal of Biological Chemistry.

[8]  M. Ronjat,et al.  Critical amino acid residues of maurocalcine involved in pharmacology, lipid interaction and cell penetration. , 2007, Biochimica et biophysica acta.

[9]  M. Ronjat,et al.  Transient loss of voltage control of Ca2+ release in the presence of maurocalcine in skeletal muscle. , 2006, Biophysical journal.

[10]  M. Ronjat,et al.  Cell penetration properties of maurocalcine, a natural venom peptide active on the intracellular ryanodine receptor. , 2006, Biochimica et biophysica acta.

[11]  M. Ronjat,et al.  Differential effects of maurocalcine on Ca2+ release events and depolarization‐induced Ca2+ release in rat skeletal muscle , 2005, The Journal of physiology.

[12]  J. Platel,et al.  Transduction of the Scorpion Toxin Maurocalcine into Cells , 2005, Journal of Biological Chemistry.

[13]  D. Grunwald,et al.  Maurocalcine and Domain A of the II-III Loop of the Dihydropyridine Receptor Cav 1.1 Subunit Share Common Binding Sites on the Skeletal Ryanodine Receptor* , 2005, Journal of Biological Chemistry.

[14]  M. Ronjat,et al.  Critical Amino Acid Residues Determine the Binding Affinity and the Ca2+ Release Efficacy of Maurocalcine in Skeletal Muscle Cells* , 2003, Journal of Biological Chemistry.

[15]  Michel De Waard,et al.  Maurocalcine and Peptide A Stabilize Distinct Subconductance States of Ryanodine Receptor Type 1, Revealing a Proportional Gating Mechanism* , 2003, The Journal of Biological Chemistry.

[16]  Doug Barrick,et al.  Limits of cooperativity in a structurally modular protein: response of the Notch ankyrin domain to analogous alanine substitutions in each repeat. , 2002, Journal of molecular biology.

[17]  U. Greber,et al.  Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake , 2002, The Journal of cell biology.

[18]  E. Blanc,et al.  A new fold in the scorpion toxin family, associated with an activity on a ryanodine‐sensitive calcium channel , 2000, Proteins.

[19]  K. Rice,et al.  A Potent New Class of Reductively Activated Peptide Gene Delivery Agents* , 2000, The Journal of Biological Chemistry.

[20]  P. Allen,et al.  Chemical synthesis and characterization of maurocalcine, a scorpion toxin that activates Ca2+ release channel/ryanodine receptors , 2000, FEBS letters.

[21]  Ü. Langel,et al.  Cell-Penetrating Peptides , 2000, Methods in Molecular Biology.

[22]  Jeffery W. Walker,et al.  Activation of Ryanodine Receptors by Imperatoxin A and a Peptide Segment of the II-III Loop of the Dihydropyridine Receptor* , 1999, The Journal of Biological Chemistry.

[23]  P. Courtoy,et al.  v-Src induces constitutive macropinocytosis in rat fibroblasts. , 1996, Journal of cell science.

[24]  M. Bretscher,et al.  Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells [published erratum appears in J Cell Biol 1990 Mar;110(3):859] , 1989, The Journal of cell biology.

[25]  N. Ikemoto,et al.  Kinetic studies of calcium release from sarcoplasmic reticulum in vitro. , 1983, The Journal of biological chemistry.

[26]  Sonia Aroui,et al.  Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: a comparative study. , 2010, Biochemical and biophysical research communications.

[27]  M. Ronjat,et al.  1 DIRECT PEPTIDE INTERACTION WITH SURFACE GLYCOSAMINOGLYCANS CONTRIBUTE TO THE CELL PENETRATION OF MAUROCALCINE , 2009 .

[28]  M S Doscher,et al.  Solid-phase peptide synthesis. , 1977, Methods in enzymology.